- Centers & Specialties
- Clinical Interests
- Gastrointestinal cancer
- Experimental therapies for GI cancers
- Medical Education
- MD, Columbia University College of Physicians and Surgeons
- Residency, Columbia University Medical Center
- Fellowship, Massachusetts General Hospital
- Board Certifications
- Medical Oncology
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Patient Age Group
A record number of participants joined the annual Four Seasons Run of Hope on September 8th to raise awareness for pediatric cancer care and research at MassGeneral Hospital for Children.
The MGH Cancer Center has received a $1.05 million gift from Sovereign Bank, N.A., a division of Santander Holdings USA, in support of its Hematology/Oncology Research Fellowship Fund.
Efforts at Massachusetts General Hospital Cancer Center are underway to address the need for more effective treatment approaches for locally advanced and metastatic disease.
The MGH celebrated the creation of the John R. Gallagher III and Katherine A. Gallagher Endowed Chair in Gastrointestinal Cancer Research.
On Oct. 12, the Department of Medicine and the Cancer Center announced the appointment of David Ryan, MD, as the new chief of Hematology/Oncology at the MGH. Ryan, who succeeds Jose Baselga, MD, PhD, joined the MGH Cancer Center in 1998.
Genotyping and Targeted Therapies Radio Ad
David P. Ryan, MD, clinical director of the Cancer Center and Tucker Gosnell Center for Gastrointestinal Cancers talks about targeted therapies and genetic testing at the Cancer Center.
Preview clip of Digestive Healthcare Center CME program
David Ryan, MD, explains the reasons for the current epidemic of esophageal cancer.
55 Fruit Street
Boston MA, 02114-2696